GREY:IPHAF - Post by User
Comment by
MementoMorion Jun 11, 2008 4:42pm
253 Views
Post# 15174169
RE: for fun : count the chicken
RE: for fun : count the chicken> before they hatch.......a 100 million cash deal for both Psoriasis andtransplant indications...excluding equity investment in the company....
The deal already in place for transplant alone (the deal that Roche can only take or leave) is worth much more than $100 million. Roche has to pay $75 million immediately upon acceptance, be responsible for 70% of all future development costs for transplant (which cost $++), and make already-negotiated milestone payments that add up, if I recall correctly, to somewhere over $200 million.
For those keeping score, $75 million in cash is $0.71 per share. If you think Roche will opt in, we are now trading, when we add in ISA's admittedly-slim current cash reserves, only a few cents above the company's cash value when they do.